对1064例1型糖尿病患者进行全外显子和全基因组测序揭示糖尿病肾病的新基因
对1064例1型糖尿病患者(541例有严重白蛋白尿或终末期肾病,523例长期正常白蛋白排泄)进行全外显子和全基因组测序及荟萃分析,未发现达到全基因组显著性的变异或基因,但提示多个基因、变异和调控区域与糖尿病肾病相关,需进一步研究验证。
要点
- 全外显子测序498例、全基因组测序599例,质控后共1064例1型糖尿病患者纳入分析。
- 单变异荟萃分析未达全基因组显著性,THAP7 rs369250变异(p=1.50×10⁻⁵,MAF=49%)在FinnGen数据中重复。
- 基因聚合荟萃分析提示NAT16和LTA等4个基因与糖尿病肾病相关,LTA rs2229092 C等位基因与较低TNFR1、TNFR2和TNFR3血清水平相关。
核心结论
- 基于测序的荟萃分析发现多个基因、变异和调控区域与糖尿病肾病提示性相关,但无变异或基因达到全基因组显著性,需进一步研究验证。
研究设计与样本
- 对498例1型糖尿病患者行全外显子测序,对599例行全基因组测序,质控后共1064例纳入分析,其中541例有严重白蛋白尿或终末期肾病,523例长期正常白蛋白排泄。
- 对蛋白质改变变异(PAV)和蛋白质截短变异(PTV)分别进行单变异和基因聚合检验,并在全外显子测序和全基因组测序数据间进行荟萃分析。
- 利用全基因组测序数据进行基因组窗口(滑动窗口)、启动子和增强子的全基因组聚合分析。
主要发现
- 单变异荟萃分析中无变异达到全基因组显著性,但常见THAP7 rs369250变异(p=1.50×10⁻⁵,MAF=49%)在FinnGen普通人群全基因组关联研究(GWAS)的慢性肾病和糖尿病肾病表型数据中重复。
- 基因聚合荟萃分析在4个基因处提供提示性证据(p<4.0×10⁻⁴),其中NAT16(MAFPAV≤10%)和LTA(又称TNFβ,MAFPAV≤5%)在FinnGen普通人群GWAS数据中重复。
- LTA rs2229092 C等位基因在部分FinnDiane参与者中与显著较低的TNFR1、TNFR2和TNFR3血清水平相关。
- 在与糖尿病肾病提示性相关的基因间区域中,染色体18q12.3上的增强子(p=3.94×10⁻⁵,MAFvariants≤5%)显示与METTL4基因交互;先导变异被重复,并预测改变MafB转录因子的结合。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无变异或基因达到全基因组显著性,需进一步研究验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetic kidney disease (DKD) is a severe diabetic complication that affects one third of individuals with type 1 diabetes. Although several genes and common variants have been shown to be associated with DKD, much of the predicted inheritance remains unexplained. Here, we performed next-generation sequencing to assess whether low-frequency variants, extending to a minor allele frequency (MAF) ≤10% (single or aggregated) contribute to the missing heritability in DKD. METHODS: We performed whole-exome sequencing (WES) of 498 individuals and whole-genome sequencing (WGS) of 599 individuals with type 1 diabetes. After quality control, next-generation sequencing data were available for a total of 1064 individuals, of whom 541 had developed either severe albuminuria or end-stage kidney disease, and 523 had retained normal albumin excretion despite a long duration of type 1 diabetes. Single-variant and gene-aggregate tests for protein-altering variants (PAV) and protein-truncating variants (PTV) were performed separately for WES and WGS data and combined in a meta-analysis. We also performed genome-wide aggregate analyses on genomic windows (sliding window), promoters and enhancers using the WGS dataset. RESULTS: In the single-variant meta-analysis, no variant reached genome-wide significance, but a suggestively associated common THAP7 rs369250 variant (p=1.50 × 10-5, MAF=49%) was replicated in the FinnGen general population genome-wide association study (GWAS) data for chronic kidney disease and DKD phenotypes. The gene-aggregate meta-analysis provided suggestive evidence (p<4.0 × 10-4) at four genes for DKD, of which NAT16 (MAFPAV≤10%) and LTA (also known as TNFβ, MAFPAV≤5%) are replicated in the FinnGen general population GWAS data. The LTA rs2229092 C allele was associated with significantly lower TNFR1, TNFR2 and TNFR3 serum levels in a subset of FinnDiane participants. Of the intergenic regions suggestively associated with DKD, the enhancer on chromosome 18q12.3 (p=3.94 × 10-5, MAFvariants≤5%) showed interaction with the METTL4 gene; the lead variant was replicated, and predicted to alter binding of the MafB transcription factor. CONCLUSIONS/INTERPRETATION: Our sequencing-based meta-analysis revealed multiple genes, variants and regulatory regions that were suggestively associated with DKD. However, as no variant or gene reached genome-wide significance, further studies are needed to validate the findings.
引用
- Haukka JK, Antikainen AA, Valo E, et al. Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease. Diabetologia. 2024. PMID: 39103720. doi:10.1007/s00125-024-06241-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。